GlassScriptPhysician profile
Stacy B Goldbaum
NPI 1760723837
$1,543.58
in general payments reported to CMS, 2019-2025
12 companies · $190 in 2025
The $190 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $676 · 2020: $126 · 2022: $59.40 · 2023: $159 · 2024: $334 · 2025: $190.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $605 · Education: $77.27.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $605.30 |
| Education | $77.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $242.62 | 2019 | |
| Novo Nordisk INC | $233.26 | 2019-2024 | Wegovy, Saxenda |
| Beta Bionics, INC. | $231.32 | 2024 | Ilet Bionic Pancreas |
| Sanofi-Aventis U.S. LLC | $215.95 | 2019 | |
| Cequr Corporation | $144.74 | 2025 | Cequr Simplicity |
| Horizon Therapeutics Plc | $125.60 | 2020 | |
| Medtronic Minimed, INC. | $119.32 | 2019 | |
| Insulet Corporation | $81.12 | 2023 | Omnipod |
| Mannkind Corporation | $59.40 | 2022 | |
| Lilly USA, LLC | $45.00 | 2025 | |
| Tandem Diabetes Care, INC. | $27.41 | 2023 | T:Slim X2 Insulin Pump With Control-Iq |
| Dexcom, INC. | $17.84 | 2023 | Dexcom G6 Transmitter |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stacy Goldbaum listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.